Federal Data Hub › SEC Fails-to-Deliver · JSON
Fails-to-deliver · CUSIP 38000Q201
Over the rolling 12-month window, securities of CRESCENT BIOPHARMA, INC. COMMO failed to deliver in the NSCC's Continuous Net Settlement system on 5 settlement days, totaling 44,819 fail shares and peaking at 36,376 shares on 2025-06-20. Persistent or spiking fails-to-deliver can signal delivery stress, naked short selling, or operational settlement problems.
| Settlement date | Fail shares | Price |
|---|---|---|
| 2025-06-24 | 7 | $15.00 |
| 2025-06-20 | 36,376 | $14.62 |
| 2025-06-18 | 490 | $13.03 |
| 2025-06-17 | 2,491 | $15.39 |
| 2025-06-16 | 5,455 | $15.70 |
A "fail-to-deliver" occurs when a party in a securities trade does not deliver the shares by the settlement date. The SEC publishes twice-monthly files of CNS fails-to-deliver by security. This page aggregates the rolling 12-month window. CUSIP 38000Q201 links to this security's other federal filings across the hub.
Source: SEC Fails-to-Deliver Data. License: CC0 1.0.